Director, Duke Stroke Center

Department / Division:
Medicine / Neurology

Address:
DUMC 3651
Durham, NC 27710

Appointment Telephone:
919-668-7600

Office Telephone:
919-684-3801

Fax Telephone:
919-684-6514

• MD, Mount Sinai School of Medicine of New York University, 1981

• Neurology, Mt. Sinai Medical Center (New York), 1981-1985

• Cerebrovascular Research, Duke University Medical Center, 1985-1987

• Board Certifications, Neurology and Vascular Neurology

Clinical Interests:
Stroke, cerebrovascular disease, TIAs, general neurology

Research Interests:
General Research Focus: Cerebrovascular Disease. Research efforts have involved several aspects of cerebrovascular disease.  In the laboratory, work has centered on developing an understanding of the mechanisms underlying pharmacological modulation of motor recovery after injury to the cerebral cortex and has led to several clinical studies in patients with stroke and traumatic brain injury.  Research in stroke has also focused on health policy issues related to the use of carotid endarterectomy and optimization of stroke prevention strategies.  Research involving new therapies for acute stroke has been carried out through clinical trials. Current focus is on identifying genes associated with small-vessel type stroke.

Specific Approaches:  Laboratory Research: Studies of recovery after sensorimotor cortex injury have focused on measurement of neurobehavioral recovery as influenced by systemically administered drugs modulating the activities of specific central neurotransmitters.  This work has involved behavioral measures, stereotactic lesioning, basic neurochemistry, cerebral microdialysis, and immunocytochemistry.  Health Policy Research:  Work has focused on clinical health policy related to cerebrovascular disease carried out in conjunction with the Center for Clinical Health Policy Research.  These studies have centered on the utilization of carotid endarterectomy and the optimization of secondary and tertiary stroke prevention with an emphasis on outcome measures.

Clinical Trials:  Principal investigator at Duke for several  stroke acute treatment trials including studies of GM1-ganglioside and several neuroprotective drugs including CGS-19755 (Selfotel), Eliprodil, and a glycine receptor anatagonist.   Principal or co-investigator at Duke for several  stroke prevention trials including the NIH-supported study of carotid angioplasty and stenting as compared with carotid endarterectomy (CREST), RESPECT (PFO closure), PROfESS (antiplatelet drugs  and angiotensin receptor blocker).  In addition, principal investigator for NIH-supported studies related to poststroke recovery and steering committee for SPARCL (statin for secondary stroke prevention).

Special Expertise: Effects of drugs on recovery after stroke and brain injury
Neuroplasticity and behavioral recovery after brain injury
Stroke trial design and outcomes measures
Carotid endarterectomy/ angioplasty-stenting
Stroke prevention (primary and secondary)
Stroke-related health policy and outcomes


Key Words:  Neurorehabilitation, stroke, cerebrovascular disease, neurobehavior, carotid endarterectomy, angioplasty, health services, prevention, outcomes

Representative Publications:
Lichtman JH, Jones SB, Wang Y, Watanabe E, Allen NB, Fayad P, Goldstein LB. Postendarterectomy mortality in octogenarians and nonagenarians in the USA from 1993 to 1999. Cerebrovasc Dis. 2010;29(2):154-61. (2010) Abstract

Goldstein LB, Rothwell PM. Advances in Prevention and Health Services Delivery 2009. Stroke. 2010 Jan 14. (2010) Abstract

Allen NB, Holford TR, Bracken MB, Goldstein LB, Howard G, Wang Y, Lichtman JH. Geographic Variation in One-Year Recurrent Ischemic Stroke Rates for Elderly Medicare Beneficiaries in the USA. Neuroepidemiology. 2010 Jan 13;34(2):123-129. (2010) Abstract

Watanabe E, Allen NB, Dostal J, Sama D, Claus EB, Goldstein LB, Lichtman JH. Diagnostic evaluation for patients with ischemic stroke: are there sex differences? Cerebrovasc Dis. 2009;27(5):450-5. (2009) Abstract

Smith Hammond CA, Goldstein LB, Horner RD, Ying J, Gray L, Gonzalez-Rothi L, Bolser DC. Predicting aspiration in patients with ischemic stroke: comparison of clinical signs and aerodynamic measures of voluntary cough. Chest. 2009 Mar;135(3):769-77. (2009) Abstract

Lichtman JH, Watanabe E, Allen NB, Jones SB, Dostal J, Goldstein LB. Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004. Stroke. 2009 Dec;40(12):3845-50. (2009) Abstract

Lichtman JH, Jones SB, Watanabe E, Allen NB, Wang Y, Howard VJ, Goldstein LB. Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization for transient ischemic attack. Stroke. 2009 Jun;40(6):2116-22. (2009) Abstract

Lichtman JH, Allen NB, Wang Y, Watanabe E, Jones SB, Goldstein LB. Stroke patient outcomes in US hospitals before the start of the Joint Commission Primary Stroke Center certification program. Stroke. 2009 Nov;40(11):3574-9. (2009) Abstract

Goldstein LB. The complex relationship between cholesterol and brain hemorrhage. Circulation. 2009 Apr 28;119(16):2131-3. (2009) Abstract

Goldstein LB. The cart and the horse: the advancing technology of carotid artery stenting. Circ Cardiovasc Interv. 2009 Jun;2(3):153-5. (2009) Abstract

Goldstein LB. The 2009 Feinberg lecture: the continuum of stroke research and policy. Stroke. 2009 Dec;40(12):3879-82. (2009) Abstract

Goldstein LB. Statins and ischemic stroke severity: cytoprotection. Curr Atheroscler Rep. 2009 Jul;11(4):296-300. (2009) Abstract

Goldstein LB. New data about stenting versus endarterectomy for symptomatic carotid artery stenosis. Curr Treat Options Cardiovasc Med. 2009 Jun;11(3):232-40. (2009) Abstract

Goldstein LB. JUPITER and the world of stroke medicine. Lancet Neurol. 2009 Feb;8(2):129-31. (2009) Abstract

Goldstein LB. Eating yourself to a stroke? Ann Neurol. 2009 Aug;66(2):129-31. (2009) Abstract

Goldstein LB. Clopidogrel plus aspirin in atrial fibrillation. N Engl J Med. 2009 Sep 24;361(13):1313; author reply 1314-5. (2009) Abstract

Goldstein LB. Amphetamine trials and tribulations. Stroke. 2009 Mar;40(3 Suppl):S133-5. (2009) Abstract

Goldstein LB, Suarez JI. The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer. Neurology. 2009 Dec 15;73(24):2058-9. (2009) Abstract

Goldstein LB, Silberberg M, McMiller Y, Yaggy SD. Stroke-related knowledge among uninsured Latino immigrants in Durham County, North Carolina. J Stroke Cerebrovasc Dis. 2009 May-Jun;18(3):229-31. (2009) Abstract

Goldstein LB, Rothwell PM. Advances in primary prevention and health services delivery. Stroke. 2009 May;40(5):e295-7. (2009) Abstract

Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, Hennerici M, MacLeod MJ, Sillesen H, Zweifler R, Michael K, Welch A, . Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2009 Nov;40(11):3526-31. (2009) Abstract

Gibbons RJ, Gardner TJ, Anderson JL, Goldstein LB, Meltzer N, Weintraub WS, Yancy CW, . The American Heart Association's principles for comparative effectiveness research: a policy statement from the American Heart Association. Circulation. 2009 Jun 9;119(22):2955-62. (2009) Abstract

Galbreath AD, Goldstein LB. Dysnomia, ataxia, choreoathetosis, sensory impairment, and gait imbalance after lentiform nucleus stroke. J Stroke Cerebrovasc Dis. 2009 Nov-Dec;18(6):494-6. (2009) Abstract

Frendl DM, Strauss DG, Underhill BK, Goldstein LB. Lack of impact of paramedic training and use of the cincinnati prehospital stroke scale on stroke patient identification and on-scene time. Stroke. 2009 Mar;40(3):754-6. (2009) Abstract

Chaturvedi S, Zivin J, Breazna A, Amarenco P, Callahan A, Goldstein LB, Hennerici M, Sillesen H, Rudolph A, Welch MA, . Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology. 2009 Feb 24;72(8):688-94. (2009) Abstract

Bushnell C, Zimmer L, Schwamm L, Goldstein LB, Clapp-Channing N, Harding T, Drew L, Zhao X, Peterson E, . The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics. Am Heart J. 2009 Mar;157(3):428-435.e2. (2009) Abstract

Amarenco P, Goldstein LB, Messig M, O'Neill BJ, Callahan A 3rd, Sillesen H, Hennerici MG, Zivin JA, Welch KM, . Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke. 2009 Jul;40(7):2486-92. (2009) Abstract

Amarenco P, Goldstein LB, Callahan A 3rd, Sillesen H, Hennerici MG, O'Neill BJ, Rudolph AE, Simunovic L, Zivin JA, Welch KM, . Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009 Jun;204(2):515-20. (2009) Abstract

Amarenco P, Benavente O, Goldstein LB, Callahan A 3rd, Sillesen H, Hennerici MG, Gilbert S, Rudolph AE, Simunovic L, Zivin JA, Welch KM, . Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke. 2009 Apr;40(4):1405-9. (2009) Abstract

Allen NB, Myers D, Watanabe E, Dostal J, Sama D, Goldstein LB, Lichtman JH. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Cerebrovasc Dis. 2009;27(3):254-8. (2009) Abstract

Adkins DL, Schallert T, Goldstein LB. Poststroke treatment: lost in translation. Stroke. 2009 Jan;40(1):8-9. (2009) Abstract

Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, Messig M, Welch KM, . Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 Dec;39(12):3297-302. (2008) Abstract

Goldstein LB. Should angioplasty and stenting be performed before CAGB in patients with asymptomatic carotid stenosis? Nat Clin Pract Neurol. 2008 May;4(5):250-1. (2008) Abstract

Goldstein LB. Reducing death and disability from stroke: the role of governmental advocacy. Stroke. 2008 Oct;39(10):2898-901. (2008) Abstract

Goldstein LB. Primary central nervous system vasculitis: is biopsy appropriate? Ann Neurol. 2008 Aug;64(2):228; author reply 229. (2008) Abstract

Goldstein LB. Minocycline treatment in acute stroke. Curr Atheroscler Rep. 2008 Aug;10(4):286-7. (2008) Abstract

Goldstein LB. How much can be gained by more systematic prevention of stroke? Int J Stroke. 2008 Nov;3(4):266-71. (2008) Abstract

Goldstein LB. Chapter 66 Stroke recovery and rehabilitation. Handb Clin Neurol. 2008;94:1327-37. (2008) Abstract

Goldstein LB. Anticoagulation for atrial fibrillation in the elderly: part 2. Curr Atheroscler Rep. 2008 Aug;10(4):285-6. (2008) Abstract

Goldstein LB. Anticoagulation for atrial fibrillation in the elderly: part 1. Curr Atheroscler Rep. 2008 Aug;10(4):284-5. (2008) Abstract

Goldstein LB. 10 questions about statins and stroke. Neurologist. 2008 Jul;14(4):262-4. (2008) Abstract

Goldstein LB, Rothwell PM. Advances in Prevention and Health Services Delivery 2007. Stroke. 2008 Jan 10. (2008) Abstract

Goldstein LB, Amarenco P, Lamonte M, Gilbert S, Messig M, Callahan A, Hennerici M, Sillesen H, Welch KM, . Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke. 2008 Sep;39(9):2444-8. (2008) Abstract

Gibbons RJ, Jones DW, Gardner TJ, Goldstein LB, Moller JH, Yancy CW, . The American Heart Association's 2008 Statement of Principles for Healthcare Reform. Circulation. 2008 Nov 18;118(21):2209-18. (2008) Abstract

Bushnell CD, Lee J, Duncan PW, Newby LK, Goldstein LB. Impact of comorbidities on ischemic stroke outcomes in women. Stroke. 2008 Jul;39(7):2138-40. (2008) Abstract

Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Sacco RL, Schwamm LH, , . Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008 May;39(5):1647-52. (2008) Abstract

Abou-Donia MB, Goldstein LB, Bullman S, Tu T, Khan WA, Dechkovskaia AM, Abdel-Rahman AA. Imidacloprid induces neurobehavioral deficits and increases expression of glial fibrillary acidic protein in the motor cortex and hippocampus in offspring rats following in utero exposure. J Toxicol Environ Health A. 2008 Jan;71(2):119-30. (2008) Abstract

Goldstein LB. Stroke code chest radiographs are not useful. Cerebrovasc Dis. 2007;24(5):460-2. (2007) Abstract

Goldstein LB. Statins for stroke prevention. Curr Atheroscler Rep. 2007 Oct;9(4):305-11. (2007) Abstract

Goldstein LB. Regulatory device approval for stroke: fair and balanced? Stroke. 2007 Jun;38(6):1737-8. (2007) Abstract

Goldstein LB. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the DEFUSE study. Curr Atheroscler Rep. 2007 Oct;9(4):258-9. (2007) Abstract

Goldstein LB. Low LDL cholesterol, statins, and brain hemorrhage: should we worry? Neurology. 2007 Mar 6;68(10):719-20. (2007) Abstract

Goldstein LB. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE trial. Curr Atheroscler Rep. 2007 Oct;9(4):259-60. (2007) Abstract

Goldstein LB. Acute ischemic stroke treatment in 2007. Circulation. 2007 Sep 25;116(13):1504-14. (2007) Abstract

Goldstein LB, Rothwell PM. Primary prevention and health services delivery. Stroke. 2007 Feb;38(2):222-4. (2007) Abstract

Goldstein LB, Amarenco P, Szarek M, Callahan A 3rd, Hennerici M, Sillesen H, Zivin JA, Welch KM, . Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2007 Dec 12. (2007) Abstract

Fletcher GF, Bufalino V, Costa F, Goldstein LB, Jones D, Smaha L, Smith SC Jr, Stone N. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. Am J Cardiol. 2007 Mar 27;99(6C):1E-35E. (2007) Abstract

Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A 3rd, Hennerici M, Simunovic L, Zivin JA, Welch KM, . Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007 Dec;38(12):3198-204. (2007) Abstract

Smith Hammond CA, Goldstein LB. Cough and aspiration of food and liquids due to oral-pharyngeal dysphagia: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):154S-168S. (2006) Abstract

Saver JL, Goldstein LB. The new standing guideline committee policy of the American Stroke Association Stroke Council. Stroke. 2006 Mar;37(3):753. (2006) Abstract

Saver JL, Goldstein LB. Response to Letter by Hart. Stroke. 2006 Jul 6. (2006) Abstract

Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T, , , . Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006 Mar 14;113(10):e409-49. (2006) Abstract

Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T, , , , . Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006 Feb;37(2):577-617. (2006) Abstract

Kaplan KL, Goldstein LB. What does cerebral platelet activation mean in the setting of carotid stenosis? Neurology. 2006 Mar 28;66(6):792-3. (2006) Abstract

Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UB, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Smith Hammond C, Tarlo SM, . Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):1S-23S. (2006) Abstract

Goldstein LB. Primum non nocere: antithombotics after intracerebral hemorrhage? Neurology. 2006 Jan 24;66(2):162-3. (2006) Abstract

Goldstein LB. Neurotransmitters and motor activity: effects on functional recovery after brain injury. NeuroRx. 2006 Oct;3(4):451-7. (2006) Abstract

Goldstein LB. Is there a causal relationship between the amount of alcohol consumption and stroke risk? Stroke. 2006 Jan;37(1):1-2. (2006) Abstract

Goldstein LB. Improving the clinical diagnosis of stroke. Stroke. 2006 Mar;37(3):754-5. (2006) Abstract

Goldstein LB, Saver JL. Thrombolysis in Stroke: a Medicolegal Quagmire. Stroke. 2006 Sep 21. (2006) Abstract

Goldstein LB, Hankey GJ. Advances in primary stroke prevention. Stroke. 2006 Feb;37(2):317-9. (2006) Abstract

Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL, , , , , , , . Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006 Jun;37(6):1583-633. (2006) Abstract

Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL, , . Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2006 Jun 20;113(24):e873-923. (2006) Abstract

Bushnell CD, Hurn P, Colton C, Miller VM, del Zoppo G, Elkind MS, Stern B, Herrington D, Ford-Lynch G, Gorelick P, James A, Brown CM, Choi E, Bray P, Newby LK, Goldstein LB, Simpkins J. Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke. 2006 Sep;37(9):2387-99. (2006) Abstract

Bushnell CD, Griffin J, Newby LK, Goldstein LB, Mahaffey KW, Graffagnino CA, Harrington RA, White HD, Simes RJ, Califf RM, Topol EJ, Easton JD. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke. 2006 Jun;37(6):1427-31. (2006) Abstract

Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, . High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 Aug 10;355(6):549-59. (2006) Abstract

Abou-Donia MB, Khan WA, Dechkovskaia AM, Goldstein LB, Bullman SL, Abdel-Rahman A. In utero exposure to nicotine and chlorpyrifos alone, and in combination produces persistent sensorimotor deficits and Purkinje neuron loss in the cerebellum of adult offspring rats. Arch Toxicol. 2006 Sep;80(9):620-31. (2006) Abstract

Schwamm LH, Pancioli A, Acker JE 3rd, Goldstein LB, Zorowitz RD, Shephard TJ, Moyer P, Gorman M, Johnston SC, Duncan PW, Gorelick P, Frank J, Stranne SK, Smith R, Federspiel W, Horton KB, Magnis E, Adams RJ, . Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke. 2005 Mar;36(3):690-703. (2005) Abstract

Schwamm LH, Pancioli A, Acker JE 3rd, Goldstein LB, Zorowitz RD, Shephard TJ, Moyer P, Gorman M, Johnston SC, Duncan PW, Gorelick P, Frank J, Stranne SK, Smith R, Federspiel W, Horton KB, Magnis E, Adams RJ, . Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation. 2005 Mar 1;111(8):1078-91. (2005) Abstract

Goldstein LB, Simel DL. Is this patient having a stroke? JAMA. 2005 May 18;293(19):2391-402. (2005) Abstract

Goldstein LB, Amarenco P. Prevention and health services delivery. Stroke. 2005 Feb;36(2):222-4. (2005) Abstract

Camilo O, Goldstein LB. Non-atherosclerotic vascular disease in the young. J Thromb Thrombolysis. 2005 Oct;20(2):93-103. (2005) Abstract

Camilo O, Goldstein LB. Lower stroke-related mortality in counties with stroke centers: North Carolina Stroke Facilities Survey. Neurology. 2005 Feb 22;64(4):762-3. (2005) Abstract

Bushnell CD, Goldstein LB. Neurologists' evaluation and treatment of hyperhomocysteinemia in stroke patients. J Stroke Cerebrovasc Dis. 2005 May-Jun;14(3):101-6. (2005) Abstract

Adams H, Adams R, Del Zoppo G, Goldstein LB, , . Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005 Apr;36(4):916-23. (2005) Abstract

Rothwell PM, Goldstein LB. Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke. 2004 Oct;35(10):2425-7. (2004) Abstract

Popp RJ, Smith SC Jr, Adams RJ, Antman EM, Kavey RE, DeMaria AN, Ohman EM, Pitt B, Willerson JT, Bellande BJ, Fonarow GC, Nishimura RA, Shah PM, Hirshfeld JW Jr, Messer JV, Peterson ED, Prystowsky EN, Anderson JL, Cheitlin MD, Goldstein LB, Grant AO, Beller GA, Hines EF Jr, Livingston DW, McEntree CW, , . ACCF/AHA consensus conference report on professionalism and ethics. Circulation. 2004 Oct 19;110(16):2506-49. (2004) Abstract

Goldstein LB. Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet. 2004 Feb 7;363(9407):414-5. (2004) Abstract

Goldstein LB. Blood pressure management in patients with acute ischemic stroke. Hypertension. 2004 Feb;43(2):137-41. (2004) Abstract

Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke. 2004 Aug;35(8):1941-5. (2004) Abstract

Goldstein LB, Amarenco P. Prevention and health services delivery. Stroke. 2004 Feb;35(2):401-3. (2004) Abstract

Goldstein LB, Amarenco P, Bogousslavsky J, Callahan AS, Hennerici MG, Welch KM, Zivin J, Sillesen H. Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. Cerebrovasc Dis. 2004;18(1):1-2. (2004) Abstract

Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke. 2004 Jul;35(7):1769-75. (2004) Abstract

Bushnell CD, Newby LK, Goldstein LB, Lin F, Yaffe K, Simon JA. Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology. 2004 Mar 23;62(6):968-70. (2004) Abstract

Bushnell CD, Goldstein LB. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology. 2004 Oct 12;63(7):1230-3. (2004) Abstract

Bonow RO, Zipes DP, Anderson JL, Cheitlin MD, Goldstein LB, Grant AO, Faxon D, Lima JA, Robertson RM. Task force 5: Expert testimony and opinions. J Am Coll Cardiol. 2004 Oct 19;44(8):1747-9. (2004) Abstract

Anderson DC, Goldstein LB. Aspirin: it's hard to beat. Neurology. 2004 Apr 13;62(7):1036-7. (2004) Abstract

Abou-Donia MB, Dechkovskaia AM, Goldstein LB, Abdel-Rahman A, Bullman SL, Khan WA. Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity. Pharmacol Biochem Behav. 2004 Feb;77(2):253-62. (2004) Abstract

Abdel-Rahman A, Dechkovskaia AM, Goldstein LB, Bullman SH, Khan W, El-Masry EM, Abou-Donia MB. Neurological deficits induced by malathion, DEET, and permethrin, alone or in combination in adult rats. J Toxicol Environ Health A. 2004 Feb 27;67(4):331-56. (2004) Abstract

Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF Jr, Smith S Jr, Stone NJ, Taubert KA, . American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation. 2003 Feb 4;107(4):645-51. (2003) Abstract

McGirt MJ, Blessing RP, Goldstein LB. Transcranial Doppler monitoring and clinical decision-making after subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2003 Mar-Apr;12(2):88-92. (2003) Abstract

Marler JR, Goldstein LB. Medicine. Stroke--tPA and the clinic. Science. 2003 Sep 19;301(5640):1677. (2003) Abstract

Goldstein LB. Prevention and health services delivery. Stroke. 2003 Feb;34(2):367-9. (2003) Abstract

Goldstein LB. Pharmacotherapy in stroke rehabilitation. Adv Neurol. 2003;92:447-50. (2003) Abstract

Goldstein LB. Neuropharmacology of TBI-induced plasticity. Brain Inj. 2003 Aug;17(8):685-94. (2003) Abstract

Goldstein LB. Model of recovery of locomotor ability after sensorimotor cortex injury in rats. ILAR J. 2003;44(2):125-9. (2003) Abstract

Goldstein LB. Extracranial carotid artery stenosis. Stroke. 2003 Nov;34(11):2767-73. (2003) Abstract

Goldstein LB. Editorial comment--Prenatal influences on stroke mortality in England and Wales. Stroke. 2003 Jul;34(7):1602-3. (2003) Abstract

Goldstein LB. Editorial comment--Advertising strategies to increase the public knowledge of the warning signs of stroke. Stroke. 2003 Aug;34(8):1968-9. (2003) Abstract

Goldstein LB. Amphetamines and related drugs in motor recovery after stroke. Phys Med Rehabil Clin N Am. 2003 Feb;14(1 Suppl):S125-34, x. (2003) Abstract

Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. Veterans Administration Acute Stroke (VASt) Study: lack of race/ethnic-based differences in utilization of stroke-related procedures or services. Stroke. 2003 Apr;34(4):999-1004. (2003) Abstract

Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology. 2003 Sep 23;61(6):792-6. (2003) Abstract

Camilo O, Goldstein LB. Statewide assessment of hospital-based stroke prevention and treatment services in North Carolina: changes over the last 5 years. Stroke. 2003 Dec;34(12):2945-50. (2003) Abstract

Bushnell C, Goldstein LB. Screening for hypercoagulable syndromes following stroke. Curr Atheroscler Rep. 2003 Jul;5(4):291-8. (2003) Abstract

Anderson DJ, Goldstein LB, Wilkinson WE, Corey GR, Cabell CH, Sanders LL, Sexton DJ. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology. 2003 Nov 25;61(10):1341-6. (2003) Abstract

Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ, . Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003 Apr;34(4):1056-83. (2003) Abstract

Abou-Donia MB, Abdel-Rahman A, Goldstein LB, Dechkovskaia AM, Shah DU, Bullman SL, Khan WA. Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats. Arch Toxicol. 2003 Aug;77(8):452-8. (2003) Abstract

Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002 Jul 16;106(3):388-91. (2002) Abstract

Johnston DC, Goldstein LB. Utility of noninvasive studies in the evaluation of patients with carotid artery disease. Curr Neurol Neurosci Rep. 2002 Jan;2(1):25-30. (2002) Abstract

Johnston DC, Eastwood JD, Nguyen T, Goldstein LB. Contrast-enhanced magnetic resonance angiography of carotid arteries: utility in routine clinical practice. Stroke. 2002 Dec;33(12):2834-8. (2002) Abstract

Goldstein LB, Lyden P, Mathias SD, Colman SS, Pasta DJ, Albers G, Atkinson R, Kelley G, Ng K, Rylander A. Telephone assessment of functioning and well-being following stroke: is it feasible? J Stroke Cerebrovasc Dis. 2002 Mar-Apr;11(2):80-7. (2002) Abstract

Goldstein LB, Bullman S. Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats. Neurorehabil Neural Repair. 2002 Dec;16(4):321-5. (2002) Abstract

Goldstein LB, Albers GW. Patient safety in trials of therapy for acute ischemic stroke. JAMA. 2002 Feb 27;287(8):987. (2002) Abstract

Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL, , . Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke. 2002 Jul;33(7):1934-42. (2002) Abstract

Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL, , . Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Neurology. 2002 Jul 9;59(1):13-22. (2002) Abstract

Bushnell CD, Goldstein LB. Physician knowledge and practices in the evaluation of coagulopathies in stroke patients. Stroke. 2002 Apr;33(4):948-53. (2002) Abstract

Bushnell CD, Goldstein LB. Homocysteine testing in patients with acute ischemic stroke. Neurology. 2002 Nov 26;59(10):1541-6. (2002) Abstract

Abou-Donia MB, Dechkovskaia AM, Goldstein LB, Shah DU, Bullman SL, Khan WA. Uranyl acetate-induced sensorimotor deficit and increased nitric oxide generation in the central nervous system in rats. Pharmacol Biochem Behav. 2002 Jul;72(4):881-90. (2002) Abstract

Abou-Donia MB, Dechkovskaia AM, Goldstein LB, Bullman SL, Khan WA. Sensorimotor deficit and cholinergic changes following coexposure with pyridostigmine bromide and sarin in rats. Toxicol Sci. 2002 Mar;66(1):148-58. (2002) Abstract

Smith Hammond CA, Goldstein LB, Zajac DJ, Gray L, Davenport PW, Bolser DC. Assessment of aspiration risk in stroke patients with quantification of voluntary cough. Neurology. 2001 Feb 27;56(4):502-6. (2001) Abstract

McDonagh DL, Goldstein LB. Examination of the stroke patient in the emergency department. Emergency Medicine 2001 (IN PRESS). (2001)

Johnston DCC, Goldstein LB. Complications of cerebral angiography in routine clinical practice are lower than expected. Neurology 2001; 57: 2012-2014. (2001)

Johnston DC, Goldstein LB. Clinical carotid endarterectomy decision making: noninvasive vascular imaging versus angiography. Neurology. 2001 Apr 24;56(8):1009-15. (2001) Abstract

Johnston DC, Chapman KM, Goldstein LB. Low rate of complications of cerebral angiography in routine clinical practice. Neurology. 2001 Dec 11;57(11):2012-4. (2001) Abstract

Goldstein LB. Underutilization of stroke preventatives. What is the solution? Proceedings of the Fifth Annual Advances in Stroke Management. Wilton, Connecticut: Chase Medical Communications, Inc., 2001; pp. 5-6. (2001)

Goldstein LB. Restorative therapy. In Fisher M. (ed.) Stroke Therapy. Woburn, MA: Butterworth Heinemann, 2001; pp. 365-376. (2001)

Goldstein LB. Medical therapy for acute ischemic stroke. Curr Atheroscler Rep. 2001 Jul;3(4):299-306. (2001) Abstract

Goldstein LB. Hyperacute stroke interventions: increasing the numbers of treatable patients. The Stroke Interventionalist 2000; 2:3-5. (2001)

Goldstein LB, Jones MR, Matchar DB, Edwards LJ, Hoff J, Chilukuri V, Armstrong SB, Horner RD. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke. 2001 May;32(5):1091-8. (2001) Abstract

Goldstein LB, Edwards MG, Wood DP. Delay between stroke onset and emergency department evaluation. Neuroepidemiology. 2001 Aug;20(3):196-200. (2001) Abstract

Goldstein LB, Alberts MJ. Ischemic stroke and TIA. In: EBM Solutions, Guidelines for Health Care Providers and Consumers [online database]. Issue 1, Nashville, TN; 2000. (2001)

Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001 Jan;32(1):280-99. (2001) Abstract

Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2001 Jan 2;103(1):163-82. (2001) Abstract

Bushnell CD, Siddiqi Z, Goldstein LB. Improving patient selection for coagulopathy testing in the setting of acute ischemic stroke. Neurology. 2001 Oct 9;57(7):1333-5. (2001) Abstract

Bushnell CD, Samsa GP, Goldstein LB. Hormone replacement therapy and ischemic stroke severity in women: a case-control study. Neurology. 2001 May 22;56(10):1304-7. (2001) Abstract

Bushnell CD, Johnston DC, Goldstein LB. Retrospective assessment of initial stroke severity: comparison of the NIH Stroke Scale and the Canadian Neurological Scale. Stroke. 2001 Mar;32(3):656-60. (2001) Abstract

Bushnell CD, Datta SK, Goldstein LB. Cost implications of specialized coagulation testing for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2001 Nov-Dec;10(6):279-83. (2001) Abstract

Bushnell C, Siddiqi Z, Morgenlander JC, Goldstein LB. Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke. Neurology. 2001 Mar 13;56(5):624-7. (2001) Abstract

Albers GW, Goldstein LB, Hall D, Lesko LM, . Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA. 2001 Dec 5;286(21):2673-82. (2001) Abstract

Albers GW, Bogousslavsky J, Bozik MA, Brass LM, Broderick JP, Fisher M, Goldstein LB, Salazar-Grueso E, Zivin JA. Recommendations for clinical trial evaluation of acute stroke therapies. Stroke Therapy Academic Industry Roundtable II (STAIR-II). Stroke 2001; 32:1598-1606. (2001)

Abou-Donia MB, Goldstein LB, Jones KH, Abdel-Rahman AA, Damodaran TV, Dechkovskaia AM, Bullman SL, Amir BE, Khan WA. Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxicol Sci. 2001 Apr;60(2):305-14. (2001) Abstract

Abou-Donia MB, Goldstein LB, Dechovskaia A, Bullman S, Jones KH, Herrick EA, Abdel-Rahman AA, Khan WA. Effects of daily dermal application of DEET and epermethrin, alone and in combination, on sensorimotor performance, blood-brain barrier, and blood-testis barrier in rats. J Toxicol Environ Health A. 2001 Apr 6;62(7):523-41. (2001) Abstract

Samsa GP, Matchar DB, Goldstein LB, Bonito AJ, Lux LJ, Witter DM, Bian J. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med. 2000 Apr 10;160(7):967-73. (2000) Abstract

Quality of Care and Outcomes Research in CVD and Stroke Working Groups. Measuring and Improving Quality of Care. A Report From the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. Circulation 2000; 101: 1483-1493. (2000)

Oddone E, Brass LM, Boos J, Goldstein LB, Alley L, Horner R, Rosen A, Kaplan L. Quality Enhancement Research Initiative in Stroke: prevention, treatment and rehabilitation. Medical Care 2000; 38: I92 - I104. (2000)

Oddone E, Booss, J, Brass LM, Coull B, Goldstein LB, Gorelick P, Horner R, Matchar D, Provenzale J, Kaplan L. Acute Stroke Management in the VA. Federal Practitioner 2000; 17: 40-58. (2000)

Goldstein LB. The use of surface electromyography in objective measurement of the muscle function in facial pain/temporomandibular dysfunction patients. Funct Orthod. 2000;17(3):26-9. (2000) Abstract

Goldstein LB. Should antihypertensive therapies be given to patients with acute ischemic stroke? Drug Saf. 2000 Jan;22(1):13-8. (2000) Abstract

Goldstein LB. Rehabilitation and Recovery After Stroke. Curr Treat Options Neurol. 2000 Jul;2(4):319-328. (2000) Abstract

Goldstein LB. Novel risk factors for stroke: homocysteine, inflammation, and infection. Curr Atheroscler Rep. 2000 Mar;2(2):110-4. (2000) Abstract

Goldstein LB. Effects of amphetamines and small related molecules on recovery after stroke in animals and man. Neuropharmacology. 2000 Mar 3;39(5):852-9. (2000) Abstract

Goldstein LB, Vitek MP, Dawson H, Bullman S. Expression of the apolipoprotein E gene does not affect motor recovery after sensorimotor cortex injury in the mouse. Neuroscience. 2000;99(4):705-10. (2000) Abstract

Goldstein LB, Howard G. Stroke in patients with asymptomatic internal-carotid-artery stenosis. N Engl J Med. 2000 Nov 9;343(19):1420; discussion 1421. (2000) Abstract

Goldstein LB, Hey LA, Laney R. North Carolina stroke prevention and treatment facilities survey. Statewide availability of programs and services. Stroke. 2000 Jan;31(1):66-70. (2000) Abstract

Goldstein LB, Bian J, Samsa GP, Bonito AJ, Lux LJ, Matchar DB. New transient ischemic attack and stroke: outpatient management by primary care physicians. Arch Intern Med. 2000 Oct 23;160(19):2941-6. (2000) Abstract

Bushnell CD, Goldstein LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke. 2000 Dec;31(12):3067-78. (2000) Abstract

Wolf PA, Clagett GP, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, Sacco RL, Whisnant JP. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 1999 Sep;30(9):1991-4. (1999) Abstract

Goldstein LB. Pharmacological approach to functional reorganization: the role of norepinephrine. Rev Neurol (Paris). 1999;155(9):731-6. (1999) Abstract

Goldstein LB. Evidence-based medicine and stroke. Neuroepidemiology. 1999;18(3):120-4. (1999) Abstract

Goldstein LB. Carotid endarterectomy. N Engl J Med. 1999 Apr 15;340(15):1209; author reply 1210-1. (1999) Abstract

Goldstein LB. Carotid endarterectomy for stroke prevention in older people. Clin Geriatr Med. 1999 Nov;15(4):685-700. (1999) Abstract

Goldstein LB. Amphetamine-facilitated poststroke recovery. Stroke. 1999 Mar;30(3):696-8. (1999) Abstract

Goldstein LB, Gradison M. Stroke-related knowledge among patients with access to medical care in the stroke belt. J Stroke Cerebrovasc Dis. 1999 September - October;8(5):349-352. (1999) Abstract

Goldstein LB, Chu CT, Gray L, Hulette CM. Angiographically defined primary angiitis of the CNS: is it really benign? Neurology. 1999 Apr 12;52(6):1302; author reply 1302-3. (1999) Abstract

Goldstein LB, Bullman S. Age but not sex affects motor recovery after unilateral sensorimotor cortex suction-ablation in the rat. Restor Neurol Neurosci. 1999;15(1):39-43. (1999) Abstract

Goldstein LB, Brott TG, Kothari RU, Smith WS. Clinical stroke trials: guarding against bias. Stroke. 1999 Jun;30(6):1165-6. (1999) Abstract

Whetten-Goldstein K, Sloan FA, Goldstein LB, Kulas ED. A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler. 1998 Oct;4(5):419-25. (1998) Abstract

Whetten-Goldstein K, Sloan F, Goldstein LB, Kulas B. A comprehensive assessment of the cost of multiple sclerosis in the United States. Multiple Sclerosis Journal 1998; 4: 419-425. (1998)

Samsa GP, Matchar DM, Goldstein LB, Bonito A, Duncan PW, Lipscomb J, Enarson C, Witter D, Venus P, Paul JE, Weinberger M. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. American Heart Journal 1998 (In Press). (1998)

Goldstein LB. Signs, symptoms, differential diagnosis and medical assessment of patients with carotid disease. In Bederson JB and Tuhrim S. Treatment of Carotid Disease: A Practitioner's Manual. Lebannon, New Hampshire: American Association of Neurological Surgeons. 1998; pp. 45-61. (1998)

Goldstein LB. Potential impact of drugs on poststroke motor recovery. Goldstein LB (ed). Restorative Neurology. Advances in the Pharmacotherapy of Recovery after Stroke. Mount Kisco: Futura Publishing Company. 1998; pp. 241-256. (1998)

Goldstein LB. Potential effects of common drugs on stroke recovery. Arch Neurol. 1998 Apr;55(4):454-6. (1998) Abstract

Goldstein LB. Pharmacologic effects on recovery of neurologic function. In Lazar RB (ed) Principles of Neurologic Rehabilitation. New York: McGraw-Hill, 1998; pp. 565-578. (1998)

Goldstein LB. Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke. 1998 Aug;29(8):1602-4. (1998) Abstract

Goldstein LB. (ed) Restorative Neurology. Advances in the Pharmacotherapy of Recovery after Stroke. Mount Kisco: Futura Publishing Company. 1998. (1998)

Goldstein LB, Samsa GP, Matchar DB, Oddone EZ. Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis. Stroke. 1998 Apr;29(4):750-3. (1998) Abstract

Goldstein LB, Hey LA, Laney R. North Carolina stroke prevention and treatment facilities survey: rtPA therapy for acute stroke. Stroke. 1998 Oct;29(10):2069-72. (1998) Abstract

Goldstein LB, Cohen SJ, Matchar DB, Samsa GP. Physician-reported readiness to change stroke prevention practices: implications for educational programs. Journal of Stroke and Cerebrovascular Disease 1998; 8: 358-363. (1998)

Goldstein LB, Cohen SJ, Matchar DB, Bonito AJ, Samsa GP. Physician-reported readiness to change stroke prevention practices. J Stroke Cerebrovasc Dis. 1998 September - October;7(5):358-363. (1998) Abstract

Chu CT, Gray L, Goldstein LB, Hulette CM. Diagnosis of intracranial vasculitis: a multi-disciplinary approach. J Neuropathol Exp Neurol. 1998 Jan;57(1):30-8. (1998) Abstract

Barnett HJM, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrumn HE, North American Symptomatic Carotid Endarterectomy Trial Collaborators* The benefit of carotid endarterectomy in symptomatic patients with moderate and severe stenosis. New England Journal of Medicine 1998; 339:1415-1425. (*endpoint adjudication committee). (1998)

Samsa GP, Cohen SJ, Goldstein LB, Bonito AJ, Duncan PW, Enarson C, DeFriese GH, Horner RD, Matchar DB. Knowledge of risk among patients at increased risk for stroke. Stroke. 1997 May;28(5):916-21. (1997) Abstract

Sacco RL, Benjamin EJ, Broderick JP, Dyken ML, Easton JD, Feinberg W, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, Manolio TA, Whisnant JP, Wolf PA: American Heart Association Prevention Conference IV: Risk Factors. Stroke. 1997;28:1507-1517. (1997)

Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, Manolio TA, Whisnant JP, Wolf PA. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke. 1997 Jul;28(7):1507-17. (1997) Abstract

Matchar DB, Oddone EZ, McCrory DC, Goldstein LB, Landsman PB, Samsa G, Brook RH, Kamberg C, Hilborne L, Leape L, Horner R. Influence of projected complication rates on estimated appropriate use rates for carotid endarterectomy. Appropriateness Project Investigators. Academic Medical Center Consortium. Health Serv Res. 1997 Aug;32(3):325-42. (1997) Abstract

Goldstein LB. Influence of common drugs and related factors on stroke outcome. Current Opinion in Neurology 1997; 10: 52-57. (1997)

Goldstein LB. Influence of common drugs and related factors on stroke outcome. Curr Opin Neurol. 1997 Feb;10(1):52-7. (1997) Abstract

Goldstein LB. Effects of bilateral and unilateral locus coeruleus lesions on beam-walking recovery after subsequent unilateral sensorimotor cortex suction-ablation in the rat. Restorative Neurology and Neuroscience 1997; 11: 55-63. (1997)

Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale: extension to non-neurologists in the context of a clinical trial. Stroke 1997; 28: 307-310. (1997)

Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke. 1997 Feb;28(2):307-10. (1997) Abstract

Goldstein LB, Moore WS, Robertson JT, Chaturvedi S. Complication rates for carotid endarterectomy. A call to action. Stroke. 1997 May;28(5):889-90. (1997) Abstract

Goldstein LB, Last FC, Salerno VM. Prevalence of hyperactive digastric muscles during swallowing as measured by electromyography in patients with myofascial pain dysfunction syndrome. Funct Orthod. 1997 May-Jul;14(3):18-22, 24. (1997) Abstract

Goldstein LB, Farmer A, Matchar DB. Primary care physician-reported secondary and tertiary stroke prevention practices. A comparison between the United States and the United Kingdom. Stroke. 1997 Apr;28(4):746-51. (1997) Abstract

Goldstein LB, Chilukuri V. Retrospective assessment of initial stroke severity with the Canadian Neurological Scale. Stroke. 1997 Jun;28(6):1181-4. (1997) Abstract

Goldstein LB, Bullman S. Effects of dorsal noradrenergic bundle lesions on recovery after sensorimotor cortex injury. Pharmacol Biochem Behav. 1997 Dec;58(4):1151-7. (1997) Abstract

Duncan PW, Samsa GP, Weinberger M, Goldstein LB, Bonito A, Witter DM, Enarson C, Matchar D. Health status of individuals with mild stroke. Stroke. 1997 Apr;28(4):740-5. (1997) Abstract

Oddone EZ, Matchar D, Goldstein LB, Pritchett ELC. Stroke prevention in a 75-year-old asymptomatic patient. Journal of Clinical Outcomes Management 1996; 3:23-35 reprinted in Hospital Physician 1996; 32: 25-48. (1996)

Goldstein LB. Stroke recovery. Neurology 1996; 46:1187-1188 (Letter Response). (1996)

Goldstein LB. Sacral pseudoradiculopathy due to centrum semiovale stroke. Journal of Stroke and Cerebrovascular Disease 1996; 6:41-44. (1996)

Goldstein LB. Sacral pseudoradiculopathy due to centrum semiovale stroke. J Stroke Cerebrovasc Dis. 1996 Sep-Oct;6(1):41-4. (1996) Abstract

Goldstein LB. Restorative Neurology. In: Wilkins RH, Rengachary SS, eds. Neurosurgery (2nd ed.) New York: McGraw-Hill Book Company, 1996; pp. 459-470. (1996)

Goldstein LB. Pharmacologic interventions for improving functional tasks and alering brain behavior. In Toole J. and Good D. (eds) Imaging in Neurorehabilitation. New York: Demos Vermande, 1996; pp. 155-169. (1996)

Goldstein LB. Pharmacologic effects on recovery of neurologic function. In Lazar RB (ed) Neurorehabilitation. New York: McGraw-Hill, 1996 (In Press). (1996)

Goldstein LB. Effects of bilateral and unilateral locus coeruleus lesions on beam-walking recovery after subsequent unilateral sensorimotor cortex suction-ablation in the rat. Restorative Neurology and Neuroscience 1996; 10 (In Press). (1996)

Goldstein LB, Roses A. Initial evaluation and treatment of the comatose patient. In: Wilkins RH, Rengachary SS, eds. Neurosurgery (2nd ed.) New York: McGraw-Hill Book Company, 1996; pp. 307-314. (1996)

Goldstein LB, Bonito AJ, Matchar DB, Duncan PW, Samsa GP. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis. Stroke. 1996 Sep;27(9):1473-8. (1996) Abstract

Goldstein LB, Bonito AJ, Matchar DB, Duncan PW, Samsa GP. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy. Stroke. 1996 May;27(5):801-6. (1996) Abstract

Goldstein LB, Bonito AJ, Matchar DB, Duncan PW, Samsa GP. U.S. National survey of physician practices for the secondary and tertiary prevention of stroke: medical therapy in patients with carotid artery stenosis. Stroke 1996; 27: 1473-1478. (1996)

Grotta J, Clark W, Coull B, Pettigrew LC, Mackay B, Goldstein LB, Meissner I, Murphy D, LaRue L. Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke. 1995 Apr;26(4):602-5. (1995) Abstract

Goldstein LB. Use of commonly prescribed medicines and novel pharmacologic approaches. In: Current Medicine: Atlas of Cerebrovascular Disease. Philadelphia: Churchill Livingstone, 1995; pp. 23.1-23.13. (1995)

Goldstein LB. Right vs. left sensorimotor cortex suction-ablation in the rat: no difference in beam-walking recovery. Brain Res. 1995 Mar 13;674(1):167-70. (1995) Abstract

Goldstein LB. Prescribing of potentially harmful drugs to patients admitted to hospital after head injury. J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):753-5. (1995) Abstract

Goldstein LB. Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators. Neurology. 1995 May;45(5):865-71. (1995) Abstract

Goldstein LB, Hasselblad V, Matchar DB, McCrory DC. Comparison and meta-analysis of randomized trials of endarterectomy for symptomatic carotid artery stenosis. Neurology. 1995 Nov;45(11):1965-70. (1995) Abstract

Goldstein LB, Gray L, Hulette CM. Stroke due to recurrent ipsilateral carotid artery dissection in a young adult. Stroke. 1995 Mar;26(3):480-3. (1995) Abstract

Goldstein LB, Gray L, Hulette CM. Stroke due to recurrent ipsilateral carotid artery dissection in a young adult, Stroke 1995; 26: 480-483. (1995)

Goldstein LB, Bonito AJ, Matchar DB, Duncan PW, DeFriese GH, Oddone EZ, Paul JE, Akin DR, Samsa GP. US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices. Stroke. 1995 Sep;26(9):1607-15. (1995) Abstract

Alberts MJ, Goldstein LB, Smith T. Guidelines on the use of thrombolytic agents in stroke. JAMA. 1995 Jul 19;274(3):218. (1995) Abstract

Alberts MJ, Goldstein LB, Smith T. Guidelines on the use of thrombolytic agents in stroke, JAMA 1995; 274:218 (Letter). (1995)

SASS Investigators. Ganglioside (GM1) in acute ischemic stroke: the SASS trial, Stroke 1994; 25:1141-1148. (1994)

Goldstein LB. Sample size calculations for clinical trials using the NIH Stroke Scale. Stroke 1994; 25: 1700-1701. (Letter) (1994)

Goldstein LB. Sample size calculations for clinical trials using the NIH Stroke Scale. Stroke. 1994 Aug;25(8):1700-1. (1994) Abstract

Goldstein LB. Pharmacologic Enhancement of Recovery. In Good DC and Couch J. (eds.) The Handbook of Neurorehabilitation. New York: Marcel Dekker, Inc., 1994; pp. 343-369. (1994)

Goldstein LB. Influence of pharmacologic agents on recovery after focal brain injury. In: Sinha KK, Chandra P, eds. Advances in the Clinical Neurosciences. Ranchi: East Zone Neuro CME, 1994; pp. 13-25. (1994)

Goldstein LB. Clinical preventive practice. Health Rep. 1994;6(1):139-41. (1994) Abstract

Goldstein LB, McCrory DC, Landsman PB, Samsa GP, Ancukiewicz M, Oddone EZ, Matchar DB. Preoperative risk factors for carotid endarterectomy.Stroke 1994; 25:2097 (Letter Response) (1994)

Goldstein LB, McCrory DC, Landsman PB, Samsa GP, Ancukiewicz M, Oddone EZ, Matchar DB. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. Stroke. 1994 Jun;25(6):1116-21. (1994) Abstract

Goldstein LB, Matchar DB. The rational clinical examination. Clinical assessment of stroke. JAMA. 1994 Apr 13;271(14):1114-20. (1994) Abstract

Goldstein LB, Matchar DB. The Stroke P.O.R.T.: secondary and tertiary prevention of ischemic stroke. Stroke Prevention Patient Outcomes Research Team. Health Rep. 1994;6(1):154-9. (1994) Abstract

Duncan PW, Goldstein LB, Horner RD, Landsman PB, Samsa GP, Matchar DB. Similar motor recovery of upper and lower extremities after stroke. Stroke. 1994 Jun;25(6):1181-8. (1994) Abstract

McCrory DC, Goldstein LB, Samsa GP, Oddone EZ, Landsman PB, Moore WS, Matchar DB. Predicting complications of carotid endarterectomy. Stroke. 1993 Sep;24(9):1285-91. (1993) Abstract

Goldstein LB. Rapid reliable measurement of lesion parameters for studies of motor recovery after sensorimotor cortex injury in the rat. J Neurosci Methods. 1993 Jun;48(1-2):35-42. (1993) Abstract

Goldstein LB. Beam-walking in rats: The measurement of motor recovery after injury to the cerebral cortex. Neuroscience Protocols 1993; 10 (3): 1-13. (1993)

Goldstein LB. Basic and clinical studies of pharmacologic effects on recovery from brain injury. J Neural Transplant Plast. 1993 Jul-Sep;4(3):175-92. (1993) Abstract

Goldstein LB, MacMillan V. Acute unilateral sensorimotor cortex injury in the rat blocks d-amphetamine induced norepinephrine release in cerebellum. Restorative Neurology and Neuroscience 1993; 5:371-376. (1993)

Goldstein LB, Perry A. Early recurrent ischemic stroke. A case-control study. Stroke. 1992 Jul;23(7):1010-3. (1992) Abstract

Goldstein LB, Coviello A. Post-lesion administration of the NMDA receptor antagonist MK-801 does not impair motor recovery after unilateral sensorimotor cortex injury in the rat. Brain Res. 1992 May 15;580(1-2):129-36. (1992) Abstract

Duncan PW, Goldstein LB, Matchar D, Divine GW, Feussner J. Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke. 1992 Aug;23(8):1084-9. (1992) Abstract

Morgenlander JC, Goldstein LB. Recurrent transient ischemic attacks and stroke in association with an internal carotid artery web. Stroke. 1991 Jan;22(1):94-8. (1991) Abstract

Massey EW, Biller J, Davis JN, Adams HP Jr, Marler JR, Goldstein LB, Alberts M, Bruno A. Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. Stroke. 1990 Sep;21(9):1289-92. (1990) Abstract

Goldstein LB. Pharmacology of recovery after stroke. Stroke. 1990 Nov;21(11 Suppl):III139-42. (1990) Abstract

Goldstein LB, Davis JN. Restorative neurology. Drugs and recovery following stroke. Stroke. 1990 Nov;21(11):1636-40. (1990) Abstract

Goldstein LB, Davis JN. Influence of lesion size and location on amphetamine-facilitated recovery of beam-walking in rats. Behav Neurosci. 1990 Apr;104(2):320-7. (1990) Abstract

Goldstein LB, Davis JN. Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. Brain Res. 1990 Feb 5;508(2):305-9. (1990) Abstract

Goldstein LB, Davis JN. Beam-walking in rats: studies towards developing an animal model of functional recovery after brain injury. J Neurosci Methods. 1990 Feb;31(2):101-7. (1990) Abstract

Goldstein LB. Centric relation and the treatment position in rehabilitating occlusions: a physiologic approach. Part I: Developing an optimum mandibular posture. J Prosthet Dent. 1989 Feb;61(2):256-7. (1989) Abstract

Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989 Jun;46(6):660-2. (1989) Abstract

Biller J, Massey EW, Marler JR, Adams HP Jr, Davis JN, Bruno A, Henriksen RA, Linhardt RJ, Goldstein LB, Alberts M. A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke. Neurology. 1989 Feb;39(2 Pt 1):262-5. (1989) Abstract

Goldstein LB, Davis JN. Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease. Neurology. 1988 Nov;38(11):1806-9. (1988) Abstract

Goldstein LB, McArdle WD, Last FC, Spina R, Lichtman S, Meyer JE, Berger AI. Temporomandibular joint repositioning and exercise performance: a double-blind study. Cranio. 1985 Sep-Dec;3(4):385-91. (1985) Abstract

McArdle WD, Goldstein LB, Last FC, Spina R, Lichtman S, Meyer JE, Berger AI. Temporomandibular joint repositioning and exercise performance: a double-blind study. Med Sci Sports Exerc. 1984 Jun;16(3):228-33. (1984) Abstract

Goldstein LB, Last FC, Berger A. Use of pulse volume plethysmography for TMJ and myofascial pain syndrome. N Y State Dent J. 1983 May;49(5):303-5. (1983) Abstract

Epstein HT, Goldstein LB. Construction of low-variability litters of preweaning mice. Dev Psychobiol. 1977 Nov;10(6):575-7. (1977) Abstract